Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.

Giovanni Tripepi; Mattace Raso Francesco; Eric Sijbrands; Mohamed Sidy Seck; Renke Maas; Rainer Böger; Jacqueline Witteman; Francesco Rapisarda; Lorenzo Malatino; Francesca Mallamaci; Carmine Zoccali

Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.

Standard

Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. / Tripepi, Giovanni; Francesco, Mattace Raso; Sijbrands, Eric; Seck, Mohamed Sidy; Maas, Renke; Böger, Rainer; Witteman, Jacqueline; Rapisarda, Francesco; Malatino, Lorenzo; Mallamaci, Francesca; Zoccali, Carmine.

in: CLIN J AM SOC NEPHRO, Jahrgang 6, Nr. 7, 7, 2011, S. 1714-1721.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Tripepi, G, Francesco, MR, Sijbrands, E, Seck, MS, Maas, R, Böger, R, Witteman, J, Rapisarda, F, Malatino, L, Mallamaci, F & Zoccali, C 2011, 'Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.', CLIN J AM SOC NEPHRO, Jg. 6, Nr. 7, 7, S. 1714-1721. <http://www.ncbi.nlm.nih.gov/pubmed/21642364?dopt=Citation>

APA

Tripepi, G., Francesco, M. R., Sijbrands, E., Seck, M. S., Maas, R., Böger, R., Witteman, J., Rapisarda, F., Malatino, L., Mallamaci, F., & Zoccali, C. (2011). Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. CLIN J AM SOC NEPHRO, 6(7), 1714-1721. [7]. http://www.ncbi.nlm.nih.gov/pubmed/21642364?dopt=Citation

Vancouver

Tripepi G, Francesco MR, Sijbrands E, Seck MS, Maas R, Böger R et al. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. CLIN J AM SOC NEPHRO. 2011;6(7):1714-1721. 7.

Bibtex

@article{fb618735622849e3bcfcc57433c3bfe4,

title = "Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.",

abstract = "Endothelial dysfunction as assessed by asymmetric dimethylarginine (ADMA) and inflammation has been consistently linked to atherosclerosis, death, and cardiovascular (CV) events in ESRD patients. Inflammation amplifies the effect of ADMA on the severity of atherosclerosis in ESRD patients, but it is still unknown whether inflammation and ADMA interact in the high risk of death and CV events in this population.",

keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Risk Factors, Cohort Studies, Prognosis, Risk Assessment, Time Factors, Proportional Hazards Models, Chi-Square Distribution, Analysis of Variance, C-Reactive Protein/metabolism, Arginine/*analogs & derivatives/blood, Biological Markers/blood, Cardiovascular Diseases/blood/immunology/*mortality, Inflammation/blood/immunology/*mortality, Inflammation Mediators/*blood, Interleukin-6/blood, Italy/epidemiology, Kidney Failure, Chronic/blood/immunology/*mortality/therapy, Renal Dialysis/adverse effects/mortality, Adult, Humans, Male, Aged, Female, Middle Aged, Risk Factors, Cohort Studies, Prognosis, Risk Assessment, Time Factors, Proportional Hazards Models, Chi-Square Distribution, Analysis of Variance, C-Reactive Protein/metabolism, Arginine/*analogs & derivatives/blood, Biological Markers/blood, Cardiovascular Diseases/blood/immunology/*mortality, Inflammation/blood/immunology/*mortality, Inflammation Mediators/*blood, Interleukin-6/blood, Italy/epidemiology, Kidney Failure, Chronic/blood/immunology/*mortality/therapy, Renal Dialysis/adverse effects/mortality",

author = "Giovanni Tripepi and Francesco, {Mattace Raso} and Eric Sijbrands and Seck, {Mohamed Sidy} and Renke Maas and Rainer B{\"o}ger and Jacqueline Witteman and Francesco Rapisarda and Lorenzo Malatino and Francesca Mallamaci and Carmine Zoccali",

year = "2011",

language = "English",

volume = "6",

pages = "1714--1721",

journal = "CLIN J AM SOC NEPHRO",

issn = "1555-9041",

publisher = "American Society of Nephrology",

number = "7",

}

RIS

TY - JOUR

T1 - Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.

AU - Tripepi, Giovanni

AU - Francesco, Mattace Raso

AU - Sijbrands, Eric

AU - Seck, Mohamed Sidy

AU - Maas, Renke

AU - Böger, Rainer

AU - Witteman, Jacqueline

AU - Rapisarda, Francesco

AU - Malatino, Lorenzo

AU - Mallamaci, Francesca

AU - Zoccali, Carmine

PY - 2011

Y1 - 2011

N2 - Endothelial dysfunction as assessed by asymmetric dimethylarginine (ADMA) and inflammation has been consistently linked to atherosclerosis, death, and cardiovascular (CV) events in ESRD patients. Inflammation amplifies the effect of ADMA on the severity of atherosclerosis in ESRD patients, but it is still unknown whether inflammation and ADMA interact in the high risk of death and CV events in this population.

AB - Endothelial dysfunction as assessed by asymmetric dimethylarginine (ADMA) and inflammation has been consistently linked to atherosclerosis, death, and cardiovascular (CV) events in ESRD patients. Inflammation amplifies the effect of ADMA on the severity of atherosclerosis in ESRD patients, but it is still unknown whether inflammation and ADMA interact in the high risk of death and CV events in this population.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Risk Factors

KW - Cohort Studies

KW - Prognosis

KW - Risk Assessment

KW - Time Factors

KW - Proportional Hazards Models

KW - Chi-Square Distribution

KW - Analysis of Variance

KW - C-Reactive Protein/metabolism

KW - Arginine/analogs & derivatives/blood

KW - Biological Markers/blood

KW - Cardiovascular Diseases/blood/immunology/mortality

KW - Inflammation/blood/immunology/mortality

KW - Inflammation Mediators/blood

KW - Interleukin-6/blood

KW - Italy/epidemiology

KW - Kidney Failure, Chronic/blood/immunology/mortality/therapy

KW - Renal Dialysis/adverse effects/mortality